Exhibit 10.1
EXECUTION VERSION
SECURITIES PURCHASE AGREEMENT
     This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of May 31,
2005, is made by and among Remote Dynamics, Inc., a corporation organized under
the laws of the State of Delaware (the “Company”), and the purchaser (the
“Purchaser”) set forth on the execution page hereof (the “Execution Page”).
BACKGROUND
     A. The Company and the Purchaser are executing and delivering this
Agreement in reliance upon the exemption from securities registration afforded
by the provisions of Regulation D (“Regulation D”), as promulgated by the United
States Securities and Exchange Commission (the “SEC”) under the Securities Act
of 1933, as amended (the “Securities Act”).
     B. Upon the terms and conditions stated in this Agreement:
          1. the Purchaser desires to exchange the 5,000 shares of the Company’s
Series A Convertible Preferred Stock, par value $.01 per share (the “Series A
Preferred Stock”), and pay an additional $750,000 in cash to the Company, in
exchange for (i) 650 shares of the Company’s Series B Convertible Preferred
Stock, par value $.01 per share (the “Series B Preferred Stock”), which Series B
Preferred Stock shall have the rights, preferences and privileges set forth in
the form of Certificate of Designation, Preferences and Rights attached hereto
as Exhibit A (the “Series B Certificate of Designation”), and (ii) a warrant in
the form attached hereto as Exhibit B (the “C-3 Warrant”) to purchase 2,000,000
shares of the Company’s common stock, par value $.01 per share (the “Common
Stock”); and the Company desires to issue such shares of Series B Preferred
Stock and the C-3 Warrant in such exchange; and
          2. the Company desires to borrow from the Purchaser, and the Purchaser
desires to loan to the Company, additional cash in the amount of $1,750,000 in
exchange for a senior secured note exchangeable, under certain circumstances,
for two warrants to purchase up to an aggregate of 2,366,667 shares of Common
Stock, in the forms attached hereto as Exhibit C (the “C-1 Warrant”) and
Exhibit D (the “C-2 Warrant”); and the Company desires to issue the Note to the
Purchaser in exchange for such funds.
The C-1 Warrant and the C-2 Warrant are together referred to herein as the
“Exchange Warrants.” The C-3 Warrant and the Exchange Warrants are together
referred to herein as the “Warrants.” The shares of Common Stock issuable upon
exercise of or otherwise pursuant to the Warrants are referred to herein as the
“Warrant Shares.” The shares of Common Stock issuable upon exercise of or
otherwise pursuant to the Exchange Warrants are referred to herein as the
“Exchange Warrant Shares.” The shares of Common Stock issuable upon conversion
of or otherwise pursuant to the Series B Preferred Stock are referred to herein
as the “Preferred Conversion Shares.” The Preferred Conversion Shares and the
Warrant Shares are together referred to herein as the “Underlying Common
Shares.” The Series B Preferred Stock, the

 

--------------------------------------------------------------------------------

 

Note, the Warrants and the Underlying Common Shares are collectively referred to
herein as the “Securities” and each of them may individually be referred to
herein as a “Security.”
     C. Concurrently with the execution of this Agreement and the Note, the
parties hereto are executing a Security Agreement in the form attached hereto as
Exhibit E (the “Security Agreement”).
     D. Pursuant to the terms of this Agreement, as a condition to the sale of
the Series B Stock and the C-3 Warrant hereunder, the parties hereto intend to
execute a Registration Rights Agreement, in the form attached hereto as
Exhibit F (the “Registration Rights Agreement”), pursuant to which the Company
shall agree to provide certain registration rights under the Securities Act and
the rules and regulations promulgated thereunder, and applicable state
securities laws. This Agreement, the Series B Certificate of Designation, the
Warrants, the Note, the Registration Rights Agreement and the Security Agreement
are collectively referred to herein as the “Transaction Documents.”
     NOW, THEREFORE, in consideration of the premises and mutual covenants
contained herein and other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the Company and the Purchaser,
intending to be legally bound, hereby agree as follows:

1.   PURCHASE AND SALE OF SECURITIES.

     (a) Issuance of Note. Subject to the terms hereof, concurrently with the
execution of this Agreement (i) the Purchaser shall pay One Million Seven
Hundred Fifty Thousand Dollars ($1,750,000) to the Company, and the Company
shall issue the Note to the Purchaser; and (ii) the Purchaser and the Company
shall execute and deliver the Security Agreement.
     (b) Sale of Series B Preferred Stock. Subject to the terms and conditions
hereof, including the conditions set forth in Sections 6 and 7, the Purchaser
shall surrender and exchange all of the 5,000 shares of Series A Preferred Stock
held by the Purchaser and shall pay an additional Seven Hundred Fifty Thousand
Dollars ($750,000) (the “Series B Purchase Price”) to the Company, and the
Company shall issue 650 shares of Series B Preferred Stock and the C-3 Warrant
to the Purchaser (the issuance of the Series B Preferred Stock hereunder shall
be deemed full satisfaction, and result in cancellation, of the Series A
Preferred Stock); and
     (c) Exchange of Note for Warrants. Subject to the terms and conditions
hereof, including Sections 6 and 7, and the terms and conditions of the Note,
the Purchaser shall surrender the Note to the Company, and in exchange for the
Note the Company shall issue to the Purchaser the C-1 and C-2 Warrants (the
“Exchange”).
     (d) The Closings. The closings of the transactions contemplated in each of
Section 1(b) hereof (the “Series B Closing”) and Section 1(c) hereof (the
“Exchange Closing,” and together with the Series B Closing, the “Closings”)
shall take place at the offices of Drinker Biddle & Reath LLP at One Logan
Square, 18th & Cherry Streets, Philadelphia, Pennsylvania 19103 at 10:00 a.m.,
Philadelphia, Pennsylvania time, on the business day immediately following the
day on which all of the applicable conditions set forth in Sections 6 and 7
below

- 2 -

--------------------------------------------------------------------------------

 

are satisfied or waived or such other time or place as the Company and the
Purchaser may mutually agree (the “Series B Closing Date” or “Exchange Closing
Date,” as applicable; each, a “Closing Date”).

2.   PURCHASER’S REPRESENTATIONS AND WARRANTIES.

     The Purchaser represents and warrants to the Company as follows:
     (a) Purchase for Own Account, Etc. The Purchaser is purchasing the
Securities for the Purchaser’s own account for investment purposes only and not
with a present view towards the public sale or distribution thereof, except
pursuant to sales that are exempt from the registration requirements of the
Securities Act and/or sales registered under the Securities Act. The Purchaser
understands that the Purchaser must bear the economic risk of this investment
indefinitely, unless the Securities are registered pursuant to the Securities
Act and any applicable state securities or blue sky laws or an exemption from
such registration is available, and that the Company has no present intention of
registering the resale of any such Securities other than as contemplated by the
Registration Rights Agreement. Notwithstanding anything in this Section 2(a) to
the contrary, by making the representations herein, the Purchaser does not agree
to hold the Securities for any minimum or other specific term and reserves the
right to dispose of the Securities at any time in accordance with or pursuant to
a registration statement or an exemption from the registration requirements
under the Securities Act and applicable state securities laws.
     (b) Accredited Investor Status. The Purchaser is an “Accredited Investor”
as that term is defined in Rule 501(a) of Regulation D.
     (c) Reliance on Exemptions. The Purchaser understands that the Securities
are being offered and sold to the Purchaser in reliance upon specific exemptions
from the registration requirements of United States federal and state securities
laws and that the Company is relying upon the truth and accuracy of, and the
Purchaser’s compliance with, the representations, warranties, agreements,
acknowledgments and understandings of the Purchaser set forth herein in order to
determine the availability of such exemptions and the eligibility of the
Purchaser to acquire the Securities.
     (d) Information. The Purchaser and its counsel, if any, have been furnished
all materials relating to the business, finances and operations of the Company
and materials relating to the offer and sale of the Securities that have been
specifically requested by the Purchaser or its counsel. Neither such inquiries
nor any other investigation conducted by the Purchaser or its counsel or any of
its representatives shall modify, amend or affect the Purchaser’s right to rely
on the Company’s representations and warranties contained in Section 3 below.
The Purchaser understands that the Purchaser’s investment in the Securities
involves a high degree of risk.
     (e) Governmental Review. The Purchaser understands that no United States
federal or state agency or any other government or governmental agency has
passed upon or made any recommendation or endorsement of the Securities.
     (f) Authorization; Enforcement. This Agreement has been duly and validly
authorized, executed and delivered on behalf of the Purchaser and is a valid and
binding

- 3 -

--------------------------------------------------------------------------------

 

agreement of the Purchaser enforceable against the Purchaser in accordance with
its terms. Each of the other Transaction Documents has been duly and validly
authorized and, when executed and delivered on behalf of the Purchaser at the
Closing in accordance with this Agreement, shall be a valid and binding
agreement of the Purchaser enforceable against the Purchaser in accordance with
its respective terms.
     (g) Residency. The Purchaser is a resident of the jurisdiction set forth
under the Purchaser’s name on the Execution Page hereto executed by the
Purchaser.
     (h) Experience of the Purchaser. The Purchaser, either alone or together
with its representatives, has such knowledge, sophistication, and experience in
business and financial matters so as to be capable of evaluating the merits and
risks of the prospective investment in the Securities, and has so evaluated the
merits and risks of such investment.
     (i) Ability of the Purchaser to Bear Risk of Investment. The Purchaser is
able to bear the economic risk of an investment in the Securities and, at the
present time, is able to afford a complete loss of such investment.
     (j) Title to Series A Preferred Stock. The Purchaser has, and immediately
prior to the date of the Series B Closing, will have good and valid title to the
shares of Series A Preferred Stock to be exchanged by the Purchaser hereunder on
the Series B Closing Date, free and clear of all liens, encumbrances, equities
or claims.
     (k) No Brokers. Other than the consulting fee to Saffron Capital Management
LLC referred to in Section 4(q), the Purchaser has taken no action that would
give rise to any claim by any person for brokerage commissions, finder’s fees or
similar payments by the Company relating to this Agreement or the transactions
contemplated hereby.
     The Purchaser’s representations and warranties made in this Article 2 are
made solely for the purpose of permitting the Company to make a determination
that the offer and sale of the Securities pursuant to this Agreement comply with
applicable U.S. federal and state securities laws and not for any other purpose.
Accordingly, the Company may not rely on such representations and warranties for
any other purpose. No Purchaser has made or hereby makes any other
representations or warranties, express or implied, to the Company in connection
with the transactions contemplated hereby.

3.   REPRESENTATIONS AND WARRANTIES OF THE COMPANY.

     Except as set forth on a Disclosure Schedule executed and delivered by the
Company to the Purchaser (the “Disclosure Schedule”) concurrently herewith, the
Company represents and warrants to the Purchaser as follows:
     (a) Organization and Qualification. The Company and each of its direct and
indirect subsidiaries (collectively, the “Subsidiaries”) is a corporation duly
organized and existing in good standing under the laws of the jurisdiction in
which it is incorporated or organized, and has the requisite corporate power to
own its properties and to carry on its business as now being conducted. The
Company and each of its Subsidiaries is duly qualified as a foreign corporation

- 4 -

--------------------------------------------------------------------------------

 

to do business and is in good standing in every jurisdiction in which the nature
of the business conducted by it makes such qualification necessary and where the
failure so to qualify or be in good standing would have a Material Adverse
Effect. For purposes of this Agreement, “Material Adverse Effect” means any
effect which, individually or in the aggregate with all other effects,
reasonably would be expected to be materially adverse to (i) the sale, issuance
or value of the Securities, (ii) the ability of the Company to perform its
obligations under this Agreement or the other Transaction Documents or (iii) the
business, operations, properties, prospects, financial condition or results of
operations of the Company and its Subsidiaries, taken as a whole; provided,
however, that any such effect resulting solely from changes affecting the
economy or financial markets generally shall not constitute a Material Adverse
Effect.
     (b) Authorization; Enforcement. (i) The Company has the requisite corporate
power and authority to enter into and perform its obligations under this
Agreement and the other Transaction Documents, to issue and sell the Securities
in accordance with the terms hereof, to issue the Conversion Shares upon
conversion of the Series B Preferred Stock in accordance with the terms thereof
and to issue the Warrant Shares upon exercise of the Warrants in accordance with
the terms thereof; (ii) the execution, delivery and performance of this
Agreement and the other Transaction Documents by the Company and the
consummation by it of the transactions contemplated hereby and thereby
(including, without limitation, the issuance of the Securities and the issuance
and reservation for issuance of the Underlying Common Shares) have been duly
authorized by the Company’s Board of Directors and no further consent or
authorization of the Company, its Board of Directors, or any committee of the
Board of Directors is required, and (iii) this Agreement constitutes, and, upon
execution and delivery by the Company of the other Transaction Documents, such
Transaction Documents will constitute, valid and binding obligations of the
Company enforceable against the Company in accordance with their terms. Neither
the execution, delivery or performance by the Company of its obligations under
this Agreement or the other Transaction Documents, nor the consummation by it of
the transactions contemplated hereby or thereby (including, without limitation,
the issuance of the Securities or the issuance or reservation for issuance of
the Underlying Common Shares) requires any consent or authorization of the
Company’s stockholders.
     (c) Capitalization. The capitalization of the Company as of the date
hereof, including the authorized capital stock, the number of shares issued and
outstanding, the number of shares issuable and reserved for issuance pursuant to
the Company’s stock option plans (including the Company’s 2005 Equity Incentive
Plan), the number of shares issuable and reserved for issuance pursuant to
securities (other than the Series B Preferred Stock and the Warrants)
exercisable or exchangeable for, or convertible into, any shares of capital
stock and the number of shares to be reserved for issuance upon conversion of
the Series B Preferred Stock and exercise of the Warrants is set forth in
Section 3(c) of the Disclosure Schedule. All of such outstanding shares of
capital stock have been, or upon issuance in accordance with the terms of any
such exercisable, exchangeable or convertible securities will be, validly
issued, fully paid and non-assessable. No shares of capital stock of the Company
(including the Conversion Shares and the Warrant Shares) are subject to
preemptive rights or any other similar rights of the stockholders of the Company
or any liens or encumbrances. Except for the Securities and as set forth in
Section 3(c) of the Disclosure Schedule, (i) there are no outstanding options,
warrants, scrip, rights to subscribe to, calls or commitments of any character
whatsoever relating to, or securities or rights convertible into or exercisable
or exchangeable for, any shares of capital stock of the Company

- 5 -

--------------------------------------------------------------------------------

 

or any of its Subsidiaries, or contracts, commitments, understandings or
arrangements by which the Company or any of its Subsidiaries is or may become
bound to issue additional shares of capital stock of the Company or any of its
Subsidiaries, nor are any such issuances, contracts, commitments, understandings
or arrangements contemplated, (ii) there are no contracts, commitments,
understandings or arrangements under which the Company or any of its
Subsidiaries is obligated to register the sale of any of its or their securities
under the Securities Act (except the Registration Rights Agreement); (iii) there
are no outstanding securities or instruments of the Company or any of its
Subsidiaries which contain any redemption or similar provisions, and there are
no contracts, commitments, understandings or arrangements by which the Company
or any of its Subsidiaries is or may become bound to redeem or otherwise acquire
any security of the Company or any of its Subsidiaries; and (iv) the Company
does not have any shareholder rights plan, “poison pill” or other anti-takeover
plans. Section 3(c) of the Disclosure Schedule sets forth all of the securities
or instruments issued by the Company or any of its Subsidiaries that contain
anti-dilution or similar provisions, and, except as and to the extent set forth
thereon, the sale and issuance of the Securities will not trigger any
anti-dilution adjustments to any such securities or instruments. The Company has
furnished to the Purchaser true and correct copies of the Company’s Certificate
of Incorporation as in effect on the date hereof (“Certificate of
Incorporation”), the Company’s Bylaws as in effect on the date hereof (the
“Bylaws”), and all other instruments and agreements governing securities
convertible into or exercisable or exchangeable for capital stock of the
Company, all of which instruments and agreements are set forth in Section 3(c)
of the Disclosure Schedule. The Company or one of its Subsidiaries has the
unrestricted right to vote, and (subject to limitations imposed by applicable
law) to receive dividends and distributions on, all capital securities of its
Subsidiaries as owned by the Company or any such Subsidiary.
     (d) Issuance of Securities. The Securities are duly authorized and, upon
issuance in accordance with the terms of this Agreement, (i) will be validly
issued, fully paid and non-assessable and free from all taxes, liens, claims and
encumbrances, (ii) will not be subject to preemptive rights, rights of first
refusal or other similar rights of stockholders of the Company or any other
person and (iii) will not impose personal liability on the holder thereof. The
Underlying Common Shares are duly authorized and reserved for issuance, and,
upon conversion of the Series B Preferred Stock and exercise of the Warrants in
accordance with the terms thereof, (x) will be validly issued, fully paid and
non-assessable, and free from all taxes, liens, claims and encumbrances,
(y) will not be subject to preemptive rights, rights of first refusal or other
similar rights of stockholders of the Company or any other person and (z) will
not impose personal liability upon the holder thereof.
     (e) No Conflicts; Consents. The execution, delivery and performance of this
Agreement and the other Transaction Documents by the Company and the
consummation by the Company of the transactions contemplated hereby and thereby
(including, without limitation, the issuance of the Securities and the issuance
and reservation for issuance of the Underlying Common Shares) will not
(i) result in a violation of the Certificate of Incorporation or Bylaws,
(ii) conflict with, or constitute a default (or an event that with notice or
lapse of time or both would become a default) under, or give to others any
rights of termination, amendment (including, without limitation, the triggering
of any anti-dilution provisions), acceleration or cancellation of, any
agreement, indenture or instrument to which the Company or any of its
Subsidiaries is a party, or (iii) assuming the receipt of the Nasdaq Listing
Department’s approval

- 6 -

--------------------------------------------------------------------------------

 

of the Company’s Supplemental Listing Application with respect to the Securities
(other than the Note), subject to stockholder approval (to the extent
stockholder approval is contemplated herein), result in a violation of any law,
rule, regulation, order, judgment or decree (including United States federal and
state securities laws, rules and regulations and rules and regulations of any
self-regulatory organizations to which either the Company or its securities are
subject) applicable to the Company or any of its Subsidiaries or by which any
property or asset of the Company or any of its Subsidiaries is bound or affected
(except, with respect to clauses (ii) and (iii), for such conflicts, defaults,
terminations, amendments, accelerations, cancellations and violations that would
not, individually or in the aggregate, have a Material Adverse Effect). Except
(v) for Listing Department approval of the Supplemental Listing Application,
(w) as may be required under the Securities Act in connection with the
performance of the Company’s obligations under the Registration Rights
Agreement, (x) for the filing of a Form D with the SEC, (y) as may be required
for compliance with applicable state securities or “blue sky” laws, or (z) as
otherwise set forth in Section 3(e) of the Disclosure Schedule, the Company is
not required to obtain any consent, approval, authorization or order of, or make
any filing or registration with, any court or governmental agency or any
regulatory or self-regulatory agency or other third party (including, without
limitation, pursuant to any Material Contract (as defined in Section 3(g)
below)) in order for it to execute and deliver this Agreement or any of the
other Transaction Documents or perform any of its obligations hereunder or
thereunder.
     (f) Compliance. The Company is not in violation of its Certificate of
Incorporation, Bylaws or other organizational documents and no Subsidiary is in
violation of any of its organizational documents. Neither the Company nor any of
its Subsidiaries is in default (and no event has occurred that with notice or
lapse of time or both would put the Company or any of its Subsidiaries in
default) under, nor has there occurred any event giving others (with notice or
lapse of time or both) any rights of termination, amendment, acceleration or
cancellation of, any agreement, indenture or instrument to which the Company or
any of its Subsidiaries is a party (including, without limitation, the Material
Contracts), except for actual or possible violations, defaults or rights that
would not, individually or in the aggregate, have a Material Adverse Effect. The
businesses of the Company and its Subsidiaries are not being conducted in
violation of any law, ordinance or regulation of any governmental entity, except
for possible violations the sanctions for which either individually or in the
aggregate have not had and would not have a Material Adverse Effect. Neither the
Company, nor any of its Subsidiaries, nor any director, officer, agent, employee
or other person acting on behalf of the Company or any Subsidiary has, in the
course of his actions for, or on behalf of, the Company or any Subsidiary, used
any corporate funds for any unlawful contribution, gift, entertainment or other
unlawful expenses relating to political activity, made any direct or indirect
unlawful payment to any foreign or domestic government official or employee from
corporate funds, violated or is in violation of any provision of the U.S.
Foreign Corrupt Practices Act of 1977, or made any bribe, rebate, payoff,
influence payment, kickback or other unlawful payment to any foreign or domestic
government official or employee. The Company and its Subsidiaries possess all
certificates, authorizations and permits issued by the appropriate federal,
state, provincial or foreign regulatory authorities that are material to the
conduct of its business, and neither the Company nor any of its Subsidiaries has
received any notice of proceeding relating to the revocation or modification of
any such certificate, authorization or permit.

- 7 -

--------------------------------------------------------------------------------

 

     (g) SEC Documents, Financial Statements. Since August 31, 2001, the Company
has timely filed (within applicable extension periods) all reports, schedules,
forms, statements and other documents required to be filed by it with the SEC
pursuant to the reporting requirements of the Securities Exchange Act of 1934,
as amended (the “Exchange Act”) (all of the foregoing filed prior to the date
hereof and all exhibits included therein and financial statements and schedules
thereto and documents incorporated by reference therein, the “SEC Documents”).
The Company has delivered to the Purchaser true and complete copies of the SEC
Documents, or such documents are available on EDGAR. As of their respective
dates, the SEC Documents complied in all material respects with the requirements
of the Exchange Act or the Securities Act, as the case may be, and the rules and
regulations of the SEC promulgated thereunder applicable to the SEC Documents,
and none of the SEC Documents, at the time they were filed with the SEC,
contained any untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they were made, not
misleading. None of the statements made in any such SEC Documents is, or has
been, required to be amended or updated under applicable law (except for such
statements as have been amended or updated in subsequent filings made prior to
the date hereof). As of their respective dates, the financial statements of the
Company included in the SEC Documents complied as to form in all material
respects with applicable accounting requirements and the published rules and
regulations of the SEC applicable with respect thereto. Such financial
statements have been prepared in accordance with U.S. generally accepted
accounting principles (“GAAP”), consistently applied, during the periods
involved (except as may be otherwise indicated in such financial statements or
the notes thereto or, in the case of unaudited interim statements, to the extent
they may not include footnotes or may be condensed or summary statements) and
fairly present in all material respects the consolidated financial position of
the Company and its consolidated Subsidiaries as of the dates thereof and the
consolidated results of their operations and cash flows for the periods then
ended (subject, in the case of unaudited statements, to normal, immaterial
year-end audit adjustments). Except as set forth in the financial statements of
the Company included in the Select SEC Documents (as defined below), the Company
has no liabilities, contingent or otherwise, other than (i) liabilities incurred
in the ordinary course of business subsequent to the date of such financial
statements and (ii) obligations under contracts and commitments incurred in the
ordinary course of business and not required under GAAP to be reflected in such
financial statements, which liabilities and obligations referred to in clauses
(i) and (ii), individually or in the aggregate, are not material to the
financial condition or operating results of the Company. Without limiting the
generality of the foregoing, the Company has either satisfied or has set aside
on its books and records provisions reasonably adequate for the satisfaction of
all Claims (as defined in the Plan of Reorganization) pursuant to the Company’s
Third Amended Joint Plan of Reorganization, dated June 28, 2004 (the “Plan of
Reorganization”). To the extent required by the rules and regulations of the SEC
applicable thereto, the Select SEC Documents contain a complete and accurate
list of all material undischarged written or oral contracts, agreements, leases
or other instruments to which the Company or any Subsidiary is a party or by
which the Company or any Subsidiary is bound or to which any of the properties
or assets of the Company or any Subsidiary is subject (each, a “Material
Contract”). Except as set forth in the Select SEC Documents, none of the
Company, its Subsidiaries or, to the best knowledge of the Company, any of the
other parties thereto is in breach or violation of any Material Contract, which
breach or violation would have a Material Adverse Effect. For purposes of this
Agreement, “Select SEC

- 8 -

--------------------------------------------------------------------------------

 

Documents” means the Company’s (A) Annual Report on Form 10-K for the fiscal
year ended August 31, 2004, as amended by the Form 10-K/A filed on December 23,
2004 (the “2004 Annual Report”), (B) Quarterly Reports on Form 10-Q for the
fiscal quarters ended November 30, 2004 and February 29, 2005 and (C) Current
Reports on Form 8-K filed since August 31, 2004.
     (h) Internal Accounting Controls. Although the Company has not implemented,
and is not yet required to implement, the requirements of Section 404 of the
Sarbanes-Oxley Act of 2002 and the rules and regulations promulgated thereunder,
the Company and each of its Subsidiaries maintains a system of internal
accounting controls sufficient to provide reasonable assurance that
(i) transactions are executed in accordance with management’s general or
specific authorizations, (ii) transactions are recorded as necessary to permit
preparation of financial statements in conformity with GAAP and to maintain
asset accountability, (iii) access to assets is permitted only in accordance
with management’s general or specific authorization, and (iv) the recorded
accountability for assets is compared with the existing assets at reasonable
intervals and appropriate action is taken with respect to any differences. The
Company has established disclosure controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the Company and designed such
disclosures controls and procedures to ensure that material information relating
to the Company, including its Subsidiaries, is made known to the certifying
officers by others within those entities, particularly during the period in
which the Company’s Annual Report on Form 10-K or Quarterly Report on Form 10-Q,
as the case may be, is being prepared. The Company’s certifying officers have
evaluated the effectiveness of the Company’s controls and procedures as of a
date within 90 days prior to the filing date of the 2004 Annual Report and the
Company’s most recently filed Quarterly Report on Form 10-Q (each such date, an
“Evaluation Date”). The Company presented in the 2004 Annual Report and its most
recently filed Quarterly Report on Form 10-Q the conclusions of the certifying
officers about the effectiveness of the disclosure controls and procedures based
on their evaluations as of the respective Evaluation Date. Since the Evaluation
Date for the 2004 Annual Report, there have been no significant changes in the
Company’s “internal controls” (as such term is defined in Item 307(b) of
Regulation S-K under the Exchange Act) or, to the Company’s knowledge, in other
factors that could significantly affect the Company’s internal controls.
     (i) Absence of Certain Changes. Except as set forth in the Select SEC
Documents, since August 31, 2004, there has been no material adverse change and
no material adverse development in the business, properties, operations,
prospects, financial condition or results of operations of the Company and its
Subsidiaries, taken as a whole. The Company does not currently expect to take
any steps to seek protection pursuant to any bankruptcy or receivership law, nor
does the Company or any of its Subsidiaries have any knowledge or reason to
believe that its creditors intend to initiate involuntary bankruptcy proceedings
with respect to the Company or any of its Subsidiaries.
     (j) Transactions With Affiliates. Except as set forth in the Select SEC
Documents, none of the officers, directors, or employees of the Company or any
of its Subsidiaries is presently a party to any transaction with the Company or
any of its Subsidiaries (other than for ordinary course services solely in their
capacity as officers, directors or employees), including any contract, agreement
or other arrangement providing for the furnishing of services to or by,
providing for rental of real or personal property to or from, or otherwise
requiring payments to or

- 9 -

--------------------------------------------------------------------------------

 

from any such officer, director or employee or any corporation, partnership,
trust or other entity in which any such officer, director, or employee has an
ownership interest of five percent or more or is an officer, director, trustee
or partner.
     (k) Absence of Litigation. Except as disclosed in the Select SEC Documents
and as set forth in Section 3(k) of the Disclosure Schedule, there is no action,
suit, proceeding, inquiry or investigation before or by any court, public board,
government agency, self-regulatory organization or body (including, without
limitation, the SEC) pending or, to the knowledge of the Company or any of its
Subsidiaries, threatened against or affecting the Company, any of its
Subsidiaries, or any of their respective directors or officers in their
capacities as such. There are no facts which, if known by a potential claimant
or governmental authority, could give rise to a claim or proceeding which, if
asserted or conducted with results unfavorable to the Company or any of its
Subsidiaries, could reasonably be expected to have a Material Adverse Effect.
     (l) Intellectual Property. Each of the Company and its Subsidiaries owns or
is duly licensed (and, in such event, has the unfettered right to grant
sublicenses) to use all patents, patent applications, trademarks, trademark
applications, trade names, service marks, copyrights, copyright applications,
licenses, permits, inventions, discoveries, processes, scientific, technical,
engineering and marketing data, object and source codes, know-how (including
trade secrets and other unpatented and/or unpatentable proprietary or
confidential information, systems or procedures) and other similar rights and
proprietary knowledge (collectively, “Intangibles”) necessary for the conduct of
its business as now being conducted and as presently contemplated to be
conducted in the future. Section 3(l) of the Disclosure Schedule sets forth a
list of all Intangibles owned and/or used by the Company in its business. To the
knowledge of the Company and its Subsidiaries, neither the Company nor any
Subsidiary of the Company infringes or is in conflict with any right of any
other person with respect to any third party Intangibles. Neither the Company
nor any of its Subsidiaries has received written notice of any pending conflict
with or infringement upon such third party Intangibles. Except as set forth on
Section 3(l) of the Disclosure Schedule, neither the Company nor any of its
Subsidiaries has entered into any consent agreement, indemnification agreement,
forbearance to sue or settlement agreement with respect to the validity of the
Company’s or its Subsidiaries’ ownership of or right to use its Intangibles and
the Company has no knowledge of any reasonable basis for any such claim to be
successful. The Intangibles are valid and enforceable and no registration
relating thereto has lapsed, expired or been abandoned or canceled or is the
subject of cancellation or other adversarial proceedings, and all applications
therefor are pending and in good standing. The Company and its Subsidiaries have
complied, in all material respects, with their respective contractual
obligations relating to the protection of the Intangibles used pursuant to
licenses. To the Company’s knowledge, no person is infringing on or violating
the Intangibles owned or used by the Company or its Subsidiaries.
     (m) Title. The Company and its Subsidiaries have good and marketable title
in fee simple to all real property and good and merchantable title to all
personal property owned by them that is material to the business of the Company
and its Subsidiaries, in each case free and clear of all liens, encumbrances and
defects except such as do not materially affect the value of such property and
do not materially interfere with the use made and proposed to be made of such
property by the Company and its Subsidiaries. Any real property and facilities
held under lease by the Company and its Subsidiaries are held by them under
valid, subsisting and enforceable

- 10 -

--------------------------------------------------------------------------------

 

leases with such exceptions as are not material and do not materially interfere
with the use made and proposed to be made of such property and buildings by the
Company and its Subsidiaries.
     (n) Tax Status. Except as set forth in the Select SEC Documents, the
Company and each of its Subsidiaries has made or filed all foreign, U.S.
federal, state, provincial and local income and all other tax returns, reports
and declarations required by any jurisdiction to which it is subject (unless and
only to the extent that the Company and each of its Subsidiaries has set aside
on its books provisions reasonably adequate for the payment of all unpaid and
unreported taxes) and has paid all taxes and other governmental assessments and
charges that are material in amount, shown or determined to be due on such
returns, reports and declarations, except those being contested in good faith
and has set aside on its books provisions reasonably adequate for the payment of
all taxes for periods subsequent to the periods to which such returns, reports
or declarations apply. Except as set forth on Section 3(n) of the Disclosure
Schedule, there are no unpaid taxes in any material amount claimed to be due by
the taxing authority of any jurisdiction, and the officers of the Company know
of no basis for any such claim. The Company has not executed a waiver with
respect to any statute of limitations relating to the assessment or collection
of any foreign, federal, state, provincial or local tax. None of the Company’s
tax returns is presently being audited by any taxing authority.
     (o) Key Employees. Each of the Company’s directors and officers and any Key
Employee (as defined below) is currently serving the Company in the capacity
disclosed in the Select SEC Documents. No Key Employee is, or is now expected to
be, in violation of any material term of any employment contract,
confidentiality, disclosure or proprietary information agreement,
non-competition agreement, or any other contract or agreement or any restrictive
covenant, and the continued employment of each Key Employee does not subject the
Company or any of its Subsidiaries to any material liability with respect to any
of the foregoing matters. Each Key Employee has entered into an employment
contract with the Company that provides for a term of employment as set forth on
Section 3(o) of the Disclosure Schedule. To the knowledge of the Company and its
Subsidiaries, no Key Employee has any intention to terminate or limit his
employment with, or services to, the Company or any of its Subsidiaries, nor is
any such Key Employee subject to any constraints which would cause such employee
to be unable to devote his full time and attention to such employment or
services. For purposes of this Agreement, “Key Employee” means the persons
listed in Section 3(o) of the Disclosure Schedule and any individual who assumes
or performs any of the duties of a Key Employee.
     (p) Employee Relations. Neither the Company nor any of its Subsidiaries is
involved in any material union labor dispute nor, to the knowledge of the
Company or any of its Subsidiaries, is any such dispute threatened. The Company
and its Subsidiaries believe that their relations with their employees are good.
No executive officer (as defined in Rule 501(f) of the Securities Act) has
notified the Company that such officer intends to leave the Company or otherwise
terminate such officer’s employment with the Company. The Company and its
Subsidiaries are in compliance with all federal, state, local and foreign laws
and regulations respecting employment and employment practices, terms and
conditions of employment and wages and hours, except where failure to be in
compliance would not, either individually or in the aggregate, result in a
Material Adverse Effect.

- 11 -

--------------------------------------------------------------------------------

 

     (q) Insurance. The Company and each of its Subsidiaries has in force fire,
casualty, product liability and other insurance policies, with extended
coverage, sufficient in amount to allow it to replace any of its material
properties or assets which might be damaged or destroyed or sufficient to cover
liabilities to which the Company may reasonably become subject, and such types
and amounts of other insurance with respect to its business and properties, on
both a per occurrence and an aggregate basis, as are customarily carried by
persons engaged in the same or similar business as the Company. No default or
event has occurred that could give rise to a default under any such policy.
     (r) Environmental Matters. There is no environmental litigation or other
environmental proceeding pending or, to the knowledge of the Company or any of
its Subsidiaries, threatened by any governmental regulatory authority or others
with respect to the current or any former business of the Company or any of its
Subsidiaries or any partnership or joint venture currently or at any time
affiliated with the Company or any of its Subsidiaries. No state of facts exists
as to environmental matters or Hazardous Substances (as defined below) that
involves the reasonable likelihood of a material capital expenditure by the
Company or any of its Subsidiaries that may otherwise have a Material Adverse
Effect. To the Company’s knowledge, no Hazardous Substances have been treated,
stored or disposed of, or otherwise deposited, in or on the properties owned or
leased by the Company or any of its Subsidiaries or by any partnership or joint
venture currently or at any time affiliated with the Company or any of its
Subsidiaries in violation of any applicable environmental laws. The
environmental compliance programs of the Company and each of its Subsidiaries
comply in all respects with all environmental laws, whether foreign, federal,
state, provincial or local, currently in effect. For purposes of this Agreement,
“Hazardous Substances” means any substance, waste, contaminant, pollutant or
material that has been determined by any governmental authority to be capable of
posing a risk of injury to health, safety, property or the environment.
     (s) Solvency. Based on the financial condition of the Company as of the
Closing Date, (i) the Company’s fair saleable value of its assets exceeds the
amount that will be required to be paid on or in respect of the Company’s
existing debts and other liabilities (including known contingent liabilities) as
they mature; (ii) the Company’s assets do not constitute unreasonably small
capital to carry on its business for the current fiscal year as now conducted
and as proposed to be conducted including its capital needs taking into account
the particular capital requirements of the business conducted by the Company,
and projected capital requirements and capital availability thereof; and
(iii) the current cash flow of the Company, together with the proceeds the
Company would receive, were it to liquidate all of its assets, after taking into
account all anticipated uses of the cash, would be sufficient to pay all amounts
on or in respect of its debt when such amounts are required to be paid. The
Company does not intend to incur debts beyond its ability to pay such debts as
they mature (taking into account the timing and amounts of cash to be payable on
or in respect of its debt).
     (t) Listing. The Common Stock is currently listed for trading on the Nasdaq
SmallCap Market (the “SmallCap Market”). The Company is not in violation of the
listing requirements of the SmallCap Market and the Company does not presently
reasonably anticipate that the Common Stock will be delisted by the SmallCap
Market during the one-year period immediately following the Closing. The Company
has not received any notice regarding the possible delisting of the Common Stock
from the SmallCap Market. On or prior to the Closing,

- 12 -

--------------------------------------------------------------------------------

 

the Company will have secured the listing of the Underlying Common Shares on the
SmallCap Market and on each other national securities exchange, automated
quotation system or over-the-counter market upon which shares of Common Stock
are currently listed (subject to official notice of issuance).
     (u) Form S-3 Eligibility. The Company is eligible to register the resale of
its Common Stock on a registration statement on Form S-3 under the Securities
Act. There exist no facts or circumstances that would prohibit or delay the
preparation and filing of a registration statement on Form S-3 with respect to
the Registrable Securities (as defined in the Registration Rights Agreement).
The Company has no basis to believe that its past or present independent public
auditors will withhold their consent to the inclusion, or incorporation by
reference, of their audit opinion concerning the Company’s financial statements
which are included in the Registration Statement required to be filed pursuant
to the Registration Rights Agreement.
     (v) Anti-Takeover Provisions. The Company and its board of directors have
taken all necessary action, if any, in order to render inapplicable any control
share acquisition, business combination, poison pill (including any distribution
under a rights agreement) or other similar anti-takeover provision under its
Certificate of Incorporation or the laws of the state of its incorporation which
is or could become applicable to the Purchaser as a result of the transactions
contemplated by this Agreement, including, without limitation, the Company’s
issuance of the Securities and any and all Purchaser’s ownership of the
Securities.
     (w) Acknowledgment Regarding The Purchaser’s Purchase of the Securities.
The Company acknowledges and agrees that the Purchaser is acting solely in the
capacity of arm’s length purchaser with respect to this Agreement and the other
Transaction Documents and the transactions contemplated hereby and thereby, and
that, as of the date of this Agreement and as of Closing, the Purchaser is not
(i) an officer or director of the Company, or (ii) an “affiliate” of the Company
(as defined in Rule 144 under the Securities Act (including any successor rule,
“Rule 144”)). The Company further acknowledges that the Purchaser is not acting
as a financial advisor or fiduciary of the Company (or in any similar capacity)
with respect to this Agreement or the other Transaction Documents and the
transactions contemplated hereby and thereby, and any advice given by a
Purchaser or any of its representatives or agents in connection with this
Agreement or the other Transaction Documents and the transactions contemplated
hereby and thereby is merely incidental to the Purchaser’s purchase of the
Securities. The Company further represents to the Purchaser that the Company’s
decision to enter into this Agreement and the other Transaction Documents has
been based solely on the independent evaluation by the Company and its
representatives.
     (x) No General Solicitation or Integrated Offering. Neither the Company nor
any distributor participating on the Company’s behalf in the transactions
contemplated hereby (if any) nor any person acting for the Company, or any such
distributor, has conducted any “general solicitation” (as such term is defined
in Regulation D) with respect to any of the Securities being offered hereby.
Neither the Company nor any of its affiliates, nor any person acting on its or
their behalf, has directly or indirectly made any offers or sales of any
security or solicited any offers to buy any security under circumstances that
would require registration of the Securities being offered hereby under the
Securities Act or cause this offering of Securities to be integrated with any
prior offering of securities of the Company for purposes of the Securities Act,
which

- 13 -

--------------------------------------------------------------------------------

 

result of such integration would require registration under the Securities Act,
or any applicable stockholder approval provisions.
     (y) No Brokers. Other than the consulting fee to Saffron Capital Management
LLC referred to in Section 4(q), the Company has taken no action that would give
rise to any claim by any person for brokerage commissions, finder’s fees or
similar payments by any Purchaser relating to this Agreement or the transactions
contemplated hereby.
     (z) Acknowledgment Regarding Securities. The number of Conversion Shares
issuable upon conversion of the Series B Preferred Stock and the number of
Warrant Shares issuable upon exercise of the Warrants may increase in certain
circumstances. The Company’s directors and executive officers have studied and
fully understand the nature of the Securities being sold hereunder. The Company
acknowledges that its obligation to issue Conversion Shares upon conversion of
the Series B Preferred Stock in accordance with the terms thereof and the
Warrant Shares upon the exercise of the Warrants in accordance with the terms
thereof is absolute and unconditional, regardless of the dilution that such
issuance may have on the ownership interests of other stockholders and the
availability of remedies provided for in any of the Transaction Documents
relating to a failure or refusal to issue any Underlying Common Shares. Taking
the foregoing into account, the Company’s Board of Directors has determined in
its good faith business judgment that the issuance of the Securities hereunder
and the consummation of the other transactions contemplated hereby are in the
best interests of the Company and its stockholders.
     (aa) Disclosure. All information relating to or concerning the Company
and/or any of its Subsidiaries set forth in this Agreement or provided to the
Purchaser pursuant to Section 2(d) hereof or otherwise in connection with the
transactions contemplated hereby is true and correct in all material respects
and the Company has not omitted to state any material fact necessary in order to
make the statements made herein or therein, in light of the circumstances under
which they were made, not misleading. No event or circumstance has occurred or
exists with respect to the Company or its Subsidiaries or their respective
businesses, properties, prospects, operations or financial conditions, which has
not been publicly disclosed but, under applicable law, rule or regulation, would
be required to be disclosed by the Company in an annual or quarterly report
filed on the date hereof by the Company under the Exchange Act.

4.   COVENANTS.

     (a) Commercially Reasonable Efforts. The parties shall use their respective
commercially reasonable efforts timely to satisfy each of the conditions
described in Sections 6 and 7 of this Agreement.
     (b) Form D; Blue Sky Laws. The Company shall file with the SEC a Form D
with respect to the Securities as required under Regulation D and provide a copy
thereof to the Purchaser promptly after such filing. The Company shall, on or
before the Closing Date, take such action as the Company shall reasonably
determine is necessary to qualify the Securities for sale to the Purchaser
pursuant to this Agreement under applicable securities or “blue sky” laws of the
states of the United States or obtain exemption therefrom, and shall provide
evidence of any such action so taken to the Purchaser on or prior to the Closing
Date. Before the beginning

- 14 -

--------------------------------------------------------------------------------

 

of the trading day immediately following the Closing Date, the Company shall
file a Form 8-K with the SEC concerning this Agreement and the transactions
contemplated hereby, which Form 8-K shall attach this Agreement and its Exhibits
as exhibits to such Form 8-K (the “8-K Filing”). As of the date of the 8-K
Filing, the Company hereby acknowledges that no Purchaser shall be in possession
of any material nonpublic information received from the Company, any of its
Subsidiaries or any of its respective officers, directors, employees or agents,
that is not disclosed in the 8-K Filing. The Company shall not, and shall cause
each of its Subsidiaries and its and each of their respective officers,
directors, employees and agents not to, provide any Purchaser with any material
nonpublic information regarding the Company or any of its Subsidiaries from and
after the 8-K Filing without the express written consent of the Purchaser;
provided, however, that a Purchaser that exercises its rights under Section 4(m)
hereof or Article XI.B, XI.C or XI.D of the Series B Certificate of Designation
shall be deemed to have given such express written consent, but only with
respect to the information obtained as a direct result of the assertion of such
rights. Subject to the foregoing, neither the Company nor any Purchaser shall
issue any press releases or any other public statements with respect to the
transactions contemplated hereby; provided, however, that the Company shall be
entitled, without the prior approval of any Purchaser, to make any press release
or other public disclosure with respect to such transactions (i) in substantial
conformity with the 8-K Filing and contemporaneously therewith and (ii) as is
required by applicable law and regulations (provided that in the case of clause
(i) the Purchaser shall be consulted by the Company in connection with any such
press release or other public disclosure prior to its release).
     (c) Reporting Status. So long as the Purchaser (or any of their respective
affiliates) beneficially owns any of the Securities, the Company shall timely
file all reports required to be filed with the SEC pursuant to the Exchange Act,
and the Company shall not terminate its status as an issuer that files reports
under the Exchange Act even if the Exchange Act or the rules and regulations
thereunder would permit such termination. In addition, the Company shall take
all actions necessary to meet the “registrant eligibility” requirements set
forth in the general instructions to Form S-3 or any successor form thereto, to
continue to be eligible to register the resale of its Common Stock on a
registration statement on Form S-3 under the Securities Act.
     (d) Use of Proceeds. The Company shall use the proceeds from the sale and
issuance of the Securities for general corporate purposes and working capital.
Such proceeds shall not be used to (i) pay dividends; (ii) pay for any increase
in executive compensation, pay any severance fee or similar payment, or make any
loan or other advance to any officer, employee, shareholder, director or other
affiliate of the Company, without the express approval of the Board of Directors
acting in accordance with past practice; (iii) purchase debt or equity
securities of any entity (including redeeming the Company’s own securities),
except for (A) evidences of indebtedness issued or fully guaranteed by the
United States of America and having a maturity of not more than one year from
the date of acquisition, (B) certificates of deposit, notes, acceptances and
repurchase agreements having a maturity of not more than one year from the date
of acquisition issued by a bank organized in the United States having capital,
surplus and undivided profits of at least $500,000,000, (C) the highest-rated
commercial paper having a maturity of not more than one year from the date of
acquisition, and (D) “Money Market” fund shares, or money market accounts fully
insured by the Federal Deposit Insurance Corporation and sponsored by banks and
other financial institutions, provided that the investments consist principally
of the types of investments described in clauses (A), (B), or (C) above;
(iv) make any investment not directly

- 15 -

--------------------------------------------------------------------------------

 

related to the current business of the Company; or (v) to satisfy any
obligations pursuant to the Plan of Reorganization, including the payment of any
Claims (as defined therein) pursuant thereto.
     (e) Financial Information. So long as the Purchaser (or any of its
respective affiliates) beneficially owns any of the Securities, the Company
shall send (via electronic transmission or otherwise) the following reports to
each the Purchaser: (i) within ten days after the filing with the SEC, a copy of
its Annual Report on Form 10-K, its Quarterly Reports on Form 10-Q, its proxy
statements and any Current Reports on Form 8-K; and (ii) within one day after
release, copies of all press releases issued by the Company or any of its
Subsidiaries.
     (f) Reservation of Shares. The Company currently has authorized and
reserved for the purpose of issuance 10,000,000 shares of Common Stock to
provide for the full conversion of the Series B Preferred Stock and issuance of
the Conversion Shares in connection therewith, the exercise of the Warrants and
the issuance of the Warrant Shares in connection therewith and as otherwise
required by the Series B Certificate of Designation, the Warrants, the Note and
the Registration Rights Agreement (collectively, the “Issuance Obligations”). In
the event such number of shares becomes insufficient to satisfy the Issuance
Obligations, the Company shall take all necessary action to authorize and
reserve such additional shares of Common Stock necessary to satisfy the Issuance
Obligations.
     (g) Listing. So long as the Purchaser (or any of its affiliates)
beneficially owns any of the Securities, the Company shall maintain the listing
of all Underlying Common Shares from time to time issuable upon conversion of
the Series B Preferred Stock and upon exercise of the Warrants on each national
securities exchange, automated quotation system or electronic bulletin board on
which shares of Common Stock are currently listed. The Company shall use
commercially reasonable efforts to continue the listing and trading of its
Common Stock on the SmallCap Market or on the Nasdaq National Market (the
“National Market”), the New York Stock Exchange (the “NYSE”) or the American
Stock Exchange (the “AMEX”) and shall comply in all respects with the reporting,
filing and other obligations under the bylaws or rules of the National
Association of Securities Dealers, Inc. (the “NASD”), such exchanges, or such
electronic system, as applicable. The Company shall promptly provide to the
Purchaser copies of any notices it receives regarding the continued eligibility
of the Common Stock for trading on any securities exchange or automated
quotation system on which securities of the same class or series issued by the
Company are then listed or quoted, if any.
     (h) Corporate Existence. So long as the Purchaser (or any of its
affiliates) beneficially owns any of the Securities, the Company shall maintain
its corporate existence, and in the event of a merger, consolidation or sale of
all or substantially all of the Company’s assets, the Company shall ensure that
the surviving or successor entity in such transaction (i) assumes the Company’s
obligations under this Agreement and the other Transaction Documents and the
agreements and instruments entered into in connection herewith and therewith
regardless of whether or not the Company would have had a sufficient number of
shares of Common Stock authorized and available for issuance in order to effect
the conversion of all the Series B Preferred Stock and exercise in full of all
Warrants outstanding as of the date of such transaction and (ii) except in the
event of a merger, consolidation of the Company into any other corporation, or
the sale or conveyance of all or substantially all of the assets of the Company

- 16 -

--------------------------------------------------------------------------------

 

where the consideration consists solely of cash, the surviving or successor
entity is a publicly traded corporation whose common stock is listed for trading
on the SmallCap Market, the National Market, the NYSE or the AMEX.
     (i) No Integrated Offerings. The Company shall not make any offers or sales
of any security (other than the Securities) under circumstances that would
require registration of the Securities being offered or sold hereunder under the
Securities Act or cause this offering of the Securities to be integrated with
any other offering of securities by the Company.
     (j) Legal Compliance. The Company shall conduct its business and the
business of its Subsidiaries in compliance with all laws, ordinances or
regulations of governmental entities applicable to such businesses, except where
the failure to do so would not have a Material Adverse Effect.
     (k) Redemptions, Dividends and Repayments of Indebtedness. Except as
contemplated hereby, so long as the Purchaser (or any of its affiliates)
beneficially owns any of the Series B Preferred Stock, the Company shall not,
without first obtaining the written approval of the holders of a majority of the
shares of Series B Preferred Stock then outstanding (which approval may be given
or withheld by such holders in their sole and absolute discretion), repurchase,
redeem or declare or pay any cash dividend or distribution on any shares of
capital stock of the Company or repay or prepay any indebtedness of the Company
other than as expressly required pursuant to the terms of such indebtedness as
in effect on the date hereof.
     (l) Information. So long as the Purchaser (or any of its affiliates)
beneficially owns any of the Securities, the Company shall furnish to the
Purchaser:
          (i) concurrently with the filing with the SEC of its annual reports on
Form 10-K, a certificate of the President, a Vice President or a senior
financial officer of the Company stating that, based upon such examination or
investigation and review of this Agreement as in the opinion of the signer is
necessary to enable the signer to express an informed opinion with respect
thereto, neither the Company nor any of its Subsidiaries is or has during such
period been in default in the performance or observance of any of the terms,
covenants or conditions hereof, or, if the Company or any of its Subsidiaries
shall be or shall have been in default, specifying all such defaults, and the
nature and period of existence thereof, and what action the Company or such
Subsidiary has taken, is taking or proposes to take with respect thereto; and
          (ii) the information the Company must deliver to any holder or to any
prospective transferee of Securities in order to permit the sale or other
transfer of such Securities pursuant to Rule 144A of the SEC or any similar rule
then in effect.
The Company shall keep at its principal executive office a true copy of this
Agreement (as at the time in effect), and cause the same to be available for
inspection at such office during normal business hours by any holder of
Securities or any prospective transferee of Securities designated by a holder
thereof.
     (m) Inspection of Properties and Books. So long as the Purchaser (or any of
its affiliates) beneficially owns any of the Securities, each the Purchaser who
then holds Securities

- 17 -

--------------------------------------------------------------------------------

 

and its representatives and agents (collectively, the “Inspectors”) shall have
the right, at the Purchaser’s expense, to visit and inspect any of the
properties of the Company and of its Subsidiaries, to examine the books of
account and records of the Company and of its Subsidiaries, to make or be
provided with copies and extracts therefrom, to discuss the affairs, finances
and accounts of the Company and of its Subsidiaries with, and to be advised as
to the same by, its and their officers, employees and independent public
accountants (and by this provision the Company authorizes such accountants to
discuss such affairs, finances and accounts, whether or not a representative of
the Company is present) all at such reasonable times and intervals and to such
reasonable extent as the Purchaser may desire; provided, however, that each
Inspector shall hold in confidence and shall not make any disclosure (except to
the Purchaser) of any such information which the Company determines in good
faith to be confidential, and of which determination the Inspectors are so
notified, unless (i) the disclosure of such information is necessary to avoid or
correct a misstatement or omission in any Registration Statement filed pursuant
to the Registration Rights Agreement (in which case the Company shall
immediately promptly (but in no event more than two trading days after receiving
notification from the Inspector) a Form 8-K with the SEC disclosing such
information), (ii) the release of such information is ordered pursuant to a
subpoena or other order from a court or government body of competent
jurisdiction, or (iii) such information has been made generally available to the
public other than by disclosure in violation of this or any other agreement. The
Purchaser agrees that it shall, upon learning that disclosure of such
information is sought in or by a court or governmental body of competent
jurisdiction or through other means, give prompt notice to the Company and allow
the Company, at its expense, to undertake appropriate action to prevent
disclosure of, or to obtain a protective order for, the information deemed
confidential.
     (n) Shareholders Rights Plan. No claim shall be made or enforced by the
Company or any director, officer, employee, representative or other person
acting on behalf of the Company that any Purchaser is an “Acquiring Person”
under any shareholders rights plan or similar plan or arrangement in effect or
hereafter adopted by the Company, or that any Purchaser could be deemed to
trigger the provisions of any such plan or arrangement, by virtue of receiving
Securities under this Agreement or any other Transaction Documents or under any
other agreement between the Company and the Purchaser.
     (o) Pledge of Securities. The Company acknowledges and agrees that the
Securities may be pledged by any Purchaser in connection with a bona fide margin
agreement or other loan or financing arrangement that is secured by the
Securities. The pledge of Securities shall not be deemed to be a transfer, sale
or assignment of the Securities hereunder, and no Purchaser effecting a pledge
of Securities shall be required to provide the Company with any notice thereof
or otherwise make any delivery to the Company pursuant to this Agreement or any
other Transaction Document. The Company shall execute and deliver such
documentation as a pledgee of the Securities may reasonably request in
connection with a pledge of the Securities to such pledgee by a Purchaser.
     (p) Variable Securities. So long as the Purchaser (or any of their
respective affiliates) beneficially owns any of the Securities, the Company
shall not, without first obtaining the written approval of the holders of a
majority of the shares of Series B Preferred Stock then outstanding (which
approval may be given or withheld by such holders in their sole and absolute
discretion), issue or sell any rights, warrants or options to subscribe for or
purchase Common

- 18 -

--------------------------------------------------------------------------------

 

Stock, or any other securities directly or indirectly convertible into or
exchangeable or exercisable for Common Stock, at an effective conversion,
exchange or exercise price that varies or may vary with the market price of the
Common Stock, including by way of one or more reset(s) to any fixed price.
     (q) Expenses. At the Closing, the Company shall pay to the Purchaser
reimbursement for the out-of-pocket expenses reasonably incurred by the
Purchaser, its affiliates and its advisors in connection with the negotiation,
preparation, execution and delivery of this Agreement and the other Transaction
Documents and the consummation of the transactions contemplated hereby and
thereby, including, without limitation, the Purchaser’s and their respective
affiliates’ and advisors’ reasonable due diligence and attorneys’ fees and
expenses (the “Expenses”); provided, however, that the Purchaser shall be
permitted, in its discretion, to deduct all of its Expenses from the aggregate
purchase price payable by the Purchaser hereunder; and provided, further, that
the aggregate amount of the Expenses payable to the Purchaser shall not exceed
$110,000.00 (the “Expense Cap”). The Company shall pay the Purchaser fifty
thousand dollars ($50,000) of this Expense Cap concurrently with the execution
of this Agreement. In addition, from time to time thereafter, upon any
Purchaser’s written request, the Company shall pay to the Purchaser such
additional Expenses (not to exceed in the aggregate the Expense Cap), if any,
not covered by such payment, in each case to the extent reasonably incurred by
the Purchaser, its affiliates or its or their advisors in connection with the
negotiation, preparation, execution and delivery of this Agreement and the other
Transaction Documents and the consummation of the transactions contemplated
hereby and thereby. In addition to the foregoing, the Company shall pay Saffron
Capital Management LLC a consulting fee in the amount of $125,000 which SDS
Capital Group SPC, Ltd. shall be entitled to deduct from the purchase price
payable by it hereunder and pay directly to Saffron Capital Management LLC.
     (r) Right of First Refusal. If the Company desires to contract with or
otherwise engage any unrelated third party to provide technical recruiting, call
center service, outsourced software engineering and integration services, or any
similar services (collectively, the “Outsourced Services”), the Company shall
give written notification (the “Outsourcing Notification”) of such desire to SDS
Capital Group SPC, Ltd. SDS Capital Group SPC, Ltd. shall have fifteen (15) days
from its receipt of the Outsourcing Notification in which to advise the Company
of its desire to appoint a designee (the “Outsourcing Designee”) to provide such
Outsourced Services to the Company. The Outsourcing Designee shall then have the
exclusive right, during the thirty (30) day period following the date on which
the Company receives written notice of such Outsourcing Designee’s appointment,
to develop and deliver to the Company a formal proposal (the “Proposal”) for the
provision of such Outsourced Services. The Company shall accept such Proposal if
the terms of the Proposal are commercially reasonable. If an Outsourcing
Designee is not appointed, or if the Outsourcing Designee fails to deliver to
the Company a Proposal in the manner described above, the Company shall have the
right to solicit and consider alternative proposals to provide such Outsourced
Services, provided, however, that if a contract to provide such Outsourced
Services is not executed within ninety (90) days after the Outsourcing
Notification, then the provisions of this Section 4(s) will apply again to the
Outsourced Services as if the initial Outsourcing Notification had ever been
provided.
     (s) Investment Oversight Committee. Effective as of the date hereof, an
investment oversight committee (the “Investment Oversight Committee”) shall be
established for the

- 19 -

--------------------------------------------------------------------------------

 

purpose of monitoring the disbursement of the net proceeds to the Corporation
(i) in connection with the Note issuance and (ii) from the issuance and sale of
the Series B Preferred Stock. The Investment Oversight Committee shall consist
of two (2) members. The initial members shall be W. Michael Smith and Raahim
Don. All expenditures of the proceeds resulting from the sales of securities by
the Corporation pursuant to the Series B Securities Purchase Agreement shall
require the unanimous, prior, written approval of the members of the Investment
Oversight Committee. The Investment Oversight Committee shall remain in
existence until the Company has used all of the proceeds received in connection
with the transactions contemplated by this Agreement.
     (t) Stockholder Approval. Promptly following the date hereof , the Company
and its Board of Directors shall (i) prepare proxy materials and solicit proxies
requesting Stockholder Approval (as defined below), (ii) call an annual or
special meeting (the “Special Meeting”) of the Company’s stockholders (which
shall be held no later than August 1, 2005, subject to any delay caused solely
by the SEC’s review of the preliminary proxy statement relating thereto or
clearance of the materials under applicable SEC rules and regulations) for the
purpose of obtaining Stockholder Approval, (iii) recommend that the Company’s
stockholders vote in favor of such approval, and (iv) otherwise use commercially
reasonable best efforts to obtain Stockholder Approval. If Stockholder Approval
is not obtained at the Special Meeting, the Company and its Board of Directors
shall continue to use commercially reasonable best efforts to obtain Stockholder
Approval until Stockholder Approval is obtained. A request for Stockholder
Approval, unless the Board of Directors receives an opinion of counsel advising
that such recommendation would constitute a breach of the directors’ fiduciary
duties imposed by applicable law, shall include a recommendation that the
Company’s stockholders vote in favor of such approval. All expenses related to
the solicitation of proxies with respect to, or otherwise incurred in connection
with, obtaining Stockholder Approval shall be borne by the Company. “Stockholder
Approval” means the affirmative vote by the holders of the requisite number of
votes cast at a meeting of stockholders to duly and validly approve (i) the
issuance of the Exchange Warrants upon exchange of the Note in accordance with
the terms and conditions thereof and of this Agreement, (ii) the issuance of the
Series B Preferred Stock and the C-3 Warrant pursuant to this Agreement, in the
event that Nasdaq requires stockholder approval of these transactions in
connection with the Supplemental Listing Application (as described in Section
4(u) below), and (iii) any other transaction contemplated hereby which respect
to which Nasdaq requires specific stockholder approval in connection with the
Supplemental Listing Application (as described in Section 4(u) below).
     (u) Nasdaq Review. Promptly following the execution of this Agreement, the
Purchaser and the Company shall cooperate to (i) submit to the Listing
Department a copy of this Agreement and any ancillary Transaction Documents that
the parties shall agree upon, for, (ii) request that the Listing Department
review the Agreement and any other submitted documents and, following such
review, approve the Company’s Supplemental Listing Application (provided,
however, that the Company shall clarify to Nasdaq in connection with such
Supplemental Listing Application that the Company does not intend to seek
Stockholder Approval of the sale and issuance of the Series B Preferred Stock or
the C-3 Warrant), and (iii) respond to any requests from the Listing Department
for further information or documentation, or to discuss any matters relating to
this Agreement and the transactions contemplated hereby.

- 20 -

--------------------------------------------------------------------------------

 

     (v) Operation of Business. Except as otherwise contemplated by this
Agreement, during the period from the date hereof to the Closing Date, the
Company shall conduct its business in the ordinary course of business and use
commercially reasonable efforts to preserve intact in all material respects the
business organization of the business, keep available the services of its
officers and employees, and maintain its present relationships with licensors,
suppliers, distributors, customers and others having significant business
relationships with it.

5.   SECURITIES TRANSFER MATTERS.

     (a) Conversion and Exercise. Upon conversion of the Series B Preferred
Stock or exercise of the Warrants by any person, (i) if the DTC Transfer
Conditions (as defined below) are satisfied, the Company shall cause its
transfer agent to electronically transmit all Underlying Common Shares by
crediting the account of such person or its nominee with the Depository Trust
Company (“DTC”) through its Deposit Withdrawal Agent Commission system; or
(ii) if the DTC Transfer Conditions are not satisfied, the Company shall issue
and deliver, or instruct its transfer agent to issue and deliver, certificates
(subject to the legend and other applicable provisions hereof and the Series B
Certificate of Designation and Warrants), registered in the name of such person
its nominee, physical certificates representing the Underlying Common Shares, as
applicable. Even if the DTC Transfer Conditions are satisfied, any person
effecting a conversion of Series B Preferred Stock or exercising Warrants may
instruct the Company to deliver to such person or its nominee physical
certificates representing the Underlying Common Shares, as applicable, in lieu
of delivering such shares by way of DTC Transfer. For purposes of this
Agreement, “DTC Transfer Conditions” means that (A) the Company’s transfer agent
is participating in the DTC Fast Automated Securities Transfer program and
(B) the certificates for the Underlying Common Shares required to be delivered
do not bear a legend and the person effecting such conversion or exercise is not
then required to return such certificate for the placement of a legend thereon.
     (b) Transfer or Resale. The Purchaser understands that (i) except as
provided in the Registration Rights Agreement, the sale or resale of the
Securities have not been and are not being registered under the Securities Act
or any state securities laws, and the Securities may not be transferred unless
(A) the transfer is made pursuant to and as set forth in an effective
registration statement under the Securities Act covering the Securities; or
(B) the Purchaser shall have delivered to the Company an opinion of counsel
(which opinion shall be in form, substance and scope customary for opinions of
counsel in comparable transactions) to the effect that the Securities to be sold
or transferred may be sold or transferred pursuant to an exemption from such
registration under the Securities Act or any state securities laws; or (C) sold
under and in compliance with Rule 144; and (ii) neither the Company nor any
other person is under any obligation to register such Securities under the
Securities Act or any state securities laws (other than pursuant to the terms of
the Registration Rights Agreement). Notwithstanding the foregoing or anything
else contained herein to the contrary, the Securities may be pledged as
collateral in connection with a bona fide margin account or other lending
arrangement, provided such pledge is consistent with applicable laws, rules and
regulations.
     (c) Legends. The Purchaser understands that the Series B Preferred Stock,
the Note and the Warrants and, until such time as the Underlying Common Shares
have been registered

- 21 -

--------------------------------------------------------------------------------

 

under the Securities Act (including registration pursuant to Rule 416
thereunder) as contemplated by the Registration Rights Agreement or otherwise
may be sold by the Purchaser under Rule 144, the certificates for the Underlying
Common Shares may bear a restrictive legend in substantially the following form:
The securities represented by this certificate have not been registered under
the Securities Act of 1933, as amended, or the securities laws of any state of
the United States or in any other jurisdiction. The securities represented
hereby may not be offered, sold or transferred in the absence of an effective
registration statement for the securities under applicable securities laws
unless offered, sold or transferred pursuant to an available exemption from the
registration requirements of those laws.
     The Company shall, immediately prior to a registration statement covering
the Securities (including, without limitation, the Registration Statement
contemplated by the Registration Rights Agreement) being declared effective,
deliver to its transfer agent an opinion letter of counsel, opining that at any
time such registration statement is effective, the transfer agent shall issue,
in connection with the issuance of the Underlying Common Shares, certificates
representing such Underlying Common Shares without the restrictive legend above,
provided such Underlying Common Shares are to be sold pursuant to the prospectus
contained in such registration statement. Upon receipt of such opinion, the
Company shall use commercially reasonable efforts to cause the transfer agent to
confirm, for the benefit of the holders, that no further opinion of counsel is
required at the time of transfer in order to issue such shares without such
restrictive legend.
     The legend set forth above shall be removed and the Company shall issue a
certificate without such legend to the holder of any Security upon which it is
stamped, if, unless otherwise required by state securities laws, (i) the sale of
such Security is registered under the Securities Act (including registration
pursuant to Rule 416 thereunder); (ii) such holder provides the Company with an
opinion of counsel, in form, substance and scope customary for opinions of
counsel in comparable transactions, to the effect that a public sale or transfer
of such Security may be made without registration under the Securities Act; or
(iii) such holder provides the Company with reasonable assurances that such
Security can be sold under Rule 144. In the event the above legend is removed
from any Security and thereafter the effectiveness of a registration statement
covering such Security is suspended or the Company determines that a supplement
or amendment thereto is required by applicable securities laws, then upon
reasonable advance written notice to the Purchaser the Company may require that
the above legend be placed on any such Security that cannot then be sold
pursuant to an effective registration statement or under Rule 144 and the
Purchaser shall cooperate in the replacement of such legend. Such legend shall
thereafter be removed when such Security may again be sold pursuant to an
effective registration statement or under Rule 144.
     (d) Transfer Agent Instruction. Upon compliance by any Purchaser with the
provisions of this Section 5 with respect to the transfer of any Securities, the
Company shall permit the transfer of such Securities and, in the case of the
transfer of Conversion Shares or Warrant Shares, promptly instruct its transfer
agent to issue one or more certificates (or effect a

- 22 -

--------------------------------------------------------------------------------

 

DTC Transfer) in such name and in such denominations as specified by the
Purchaser. The Company shall not give any instructions to its transfer agent
with respect to the Securities, other than any permissible or required
instructions provided in this Section 5, and the Securities shall otherwise be
freely transferable on the books and records of the Company as and to the extent
provided in this Agreement.

6.   CONDITIONS TO THE COMPANY’S OBLIGATIONS TO ISSUE SECURITIES AT THE
CLOSINGS.

     (a) Conditions to Both Closings. The obligation of the Company hereunder to
issue and sell the Series B Preferred Stock and C-3 Warrant to the Purchaser
hereunder is subject to the satisfaction, at or before the Series B Closing
Date, and the obligation of the Company hereunder to issue and sell the C-1
Warrant and C-2 Warrant to the Purchaser hereunder is subject to the
satisfaction, at or before the Exchange Closing Date, of each of the following
conditions, provided that such conditions are for the Company’s sole benefit and
may be waived by the Company at any time in its sole discretion:
          (i) Bridge Loan. The parties hereto shall have consummated the loan
and issuance of the Note contemplated in Section 1(a) hereof.
          (ii) Execution of Transaction Documents. The Purchaser shall have
executed the Purchaser’s Execution Page to this Agreement and each other
Transaction Document to which the Purchaser is a party and delivered the same to
the Company.
          (iii) Nasdaq Approval. The Nasdaq Stock Market, Inc. Listing
Qualifications Department (the “Listing Department”) shall have advised the
Company of the Listing Department’s approval of the Company’s Supplemental
Listing Application, subject to stockholder approval of the issuance of the C-1
Warrant and the C-2 Warrant in connection with the Exchange.
          (iv) Representations and Warranties True; Covenants Performed. The
representations and warranties of the Purchaser shall be true and correct in all
material respects as of the date when made and as of such Closing Date as though
made at that time (except for representations and warranties that speak as of a
specific date, which representations and warranties shall be true and correct as
of such date), and the Purchaser shall have performed, satisfied and complied
with the covenants, agreements and conditions required by this Agreement to be
performed, satisfied or complied with by the Purchaser at or prior to such
Closing Date.
          (v) No Legal Prohibition. No statute, rule, regulation, executive
order, decree, ruling, injunction, action or proceeding shall have been enacted,
entered, promulgated or endorsed by any court or governmental authority of
competent jurisdiction or any self-regulatory organization having authority over
the matters contemplated hereby which restricts or prohibits the consummation of
any of the transactions contemplated by this Agreement.
     (b) Additional Conditions to Series B Closing. The obligation of the
Company hereunder to issue and sell the Series B Preferred Stock and C-3 Warrant
to the Purchaser hereunder is subject to the satisfaction, at or before the
Series B Closing Date, of each of the

- 23 -

--------------------------------------------------------------------------------

 

following additional conditions, provided that such conditions are for the
Company’s sole benefit and may be waived by the Company at any time in its sole
discretion:
          (i) Stockholder Approval. The Company shall have obtained Stockholder
Approval with respect to the sale and issuance of the Series B Preferred Stock
and C-3 Warrant, if Nasdaq requires such Stockholder Approval as a condition to
the sale and issuance of the Series B Preferred Stock and C-3 Warrant (as
described in Section 4(u) hereof).
          (ii) Payment of Purchase Price. The Purchaser shall have delivered the
full amount of the Series B Purchase Price to the Company by wire transfer in
accordance with the Company’s written wiring instructions.
     (c) Additional Conditions to Exchange Closing. The obligation of the
Company hereunder to issue and sell the C-1 Warrant and C-2 Warrant to the
Purchaser hereunder is subject to the satisfaction, at or before the Exchange
Closing Date, of each of the following conditions, provided that such conditions
are for the Company’s sole benefit and may be waived by the Company at any time
in its sole discretion:
          (i) Stockholder Approval. The Company shall have obtained Stockholder
Approval with respect to the sale and issuance of the C-1 Warrant and the C-2
Warrant.
          (ii) The Purchaser shall surrendered the Note to the Company for
exchange pursuant to the terms thereof.

7.   CONDITIONS TO THE PURCHASER’S OBLIGATIONS TO PURCHASE SECURITIES AT THE
CLOSINGS.

     (a) Conditions to Both Closings. The obligation of the Purchaser to
exchange the Series A Preferred Stock and pay cash to purchase the Series B
Preferred Stock and C-3 Warrant hereunder is subject to the satisfaction, at or
before the Series B Closing Date, and the obligation of the Purchaser to
exchange the Note for the C-1 Warrant and C-2 Warrant hereunder is subject to
the satisfaction, at or before the Exchange Closing Date, of each of the
following conditions, provided that such conditions are for the Purchaser’s sole
benefit and may be waived by the Purchaser at any time in its sole discretion:
          (i) Bridge Loan. The parties hereto shall have consummated the loan
and issuance of the Note contemplated in Section 1(a) hereof.
          (ii) Execution of Transaction Documents. The Company shall have
executed the Company’s Execution Page to this Agreement and each other
Transaction Document to which the Company is a party (other than the Warrants)
and delivered executed originals of the same to the Purchaser.
          (iii) Nasdaq Approval. The Listing Department shall have advised the
Company of the Listing Department’s approval of the Company’s Supplemental
Listing Application, subject to stockholder approval of the issuance of the C-1
Warrant and the C-2 Warrant in connection with the Exchange.

- 24 -

--------------------------------------------------------------------------------

 

          (iv) Filing of Certificate of Designation. The Certificate of
Designation shall have been filed and accepted for filing with the Secretary of
State of the State of Delaware and a copy thereof certified by the Secretary of
State of the State of Delaware shall have been delivered to the Purchaser.
          (v) Listing. The Common Stock shall be authorized for quotation and
listed on the SmallCap Market and trading in the Common Stock (or on the
SmallCap Market generally) shall not have been suspended by the SEC or the
SmallCap Market.
          (vi) Representations and Warranties True; Covenants Performed. The
representations and warranties of the Company, to the extent qualified by
materiality or Material Adverse Effect, shall be true and correct as of the date
when made and as of the Closing Date as though made at that time (except for
representations and warranties that speak as of a specific date, which
representations and warranties shall be true and correct as of such date); the
representations and warranties of the Company, to the extent not qualified by
materiality or Material Adverse Effect, shall be true and correct in all
material respects as of the date when made and as of the Closing Date as though
made at that time (except for representations and warranties that speak as of a
specific date, which representations and warranties shall be true and correct in
all material respects as of such date); and the Company shall have performed,
satisfied and complied with the covenants, agreements and conditions required by
this Agreement to be performed, satisfied or complied with by the Company at or
prior to the Closing Date. The Purchaser shall have received a certificate,
executed by the Chief Executive Officer of the Company after reasonable
investigation, dated as of the Closing Date, to the foregoing effect and as to
such other matters as may reasonably be requested by the Purchaser.
          (vii) No Legal Prohibition. No statute, rule, regulation, executive
order, decree, ruling, injunction, action or proceeding shall have been enacted,
entered, promulgated or endorsed by any court or governmental authority of
competent jurisdiction or any self-regulatory organization having authority over
the matters contemplated hereby which restricts or prohibits the consummation
of, any of the transactions contemplated by this Agreement.
          (viii) Legal Opinion. The Purchaser shall have received an opinion of
the Company’s counsel, dated as of the Closing Date, in the substantially the
same form as the legal opinion of Company’s counsel delivered to the Purchaser
in connection with the sale and issuance of the Series A Preferred Stock to the
Purchaser.
          (ix) No Material Adverse Change. There shall have been no material
adverse changes and no material adverse developments in the business,
properties, operations, prospects, financial condition or results of operations
of the Company and its Subsidiaries, taken as a whole, since the date hereof.
          (x) Corporate Approvals. The Purchaser shall have received a copy of
resolutions, duly adopted by the Board of Directors of the Company, which shall
be in full force and effect at the time of the Closing, authorizing the
execution, delivery and performance by the Company of this Agreement and the
other Transaction Documents and the consummation by the Company of the
transactions contemplated hereby and thereby, certified as such by the Secretary

- 25 -

--------------------------------------------------------------------------------

 

or Assistant Secretary of the Company, and such other documents they reasonably
request in connection with the Closing.
     (b) Additional Conditions to Series B Closing. The obligation of the
Purchaser hereunder to exchange the Series A Preferred Stock and pay cash to
purchase the Series B Preferred Stock and C-3 Warrant is subject to the
satisfaction, at or before the Series B Closing Date, of each of the following
additional conditions, provided that such conditions are for the Purchaser’s
sole benefit and may be waived by the Purchaser at any time in its sole
discretion:
          (i) Stockholder Approval. The Company shall have obtained Stockholder
Approval with respect to the sale and issuance of the Series B Preferred Stock
and C-3 Warrant, if Nasdaq requires such Stockholder Approval as a condition to
the sale and issuance of the Series B Preferred Stock and C-3 Warrant (as
described in Section 4(u) hereof).
          (ii) Delivery of Securities. The Company shall have delivered to the
Purchaser (i) duly executed certificates representing the Series B Preferred
Stock and (ii) the duly executed C-3 Warrant (each in proper form and in such
denominations as the Purchaser shall reasonably request), registered in the
Purchaser’s name.
     (c) Additional Conditions to Exchange Closing. The obligation of the
Company hereunder to exchange the Note for the C-1 Warrant and C-2 Warrant
hereunder is subject to the satisfaction, at or before the Exchange Closing
Date, of each of the following additional conditions, provided that such
conditions are for the Purchaser’s sole benefit and may be waived by the
Purchaser at any time in its sole discretion:
          (i) Stockholder Approval. The Company shall have obtained Stockholder
Approval with respect to the sale and issuance of the C-1 Warrant and the C-2
Warrant.
          (ii) Delivery of Securities. The Company shall have delivered to the
Purchaser the duly executed C-1 Warrant and C-2 Warrant (each in proper form and
in such denominations as the Purchaser shall reasonably request), registered in
the Purchaser’s name.

8.   GOVERNING LAW; MISCELLANEOUS.

     (a) Governing Law; Jurisdiction. This Agreement shall be governed by and
construed in accordance with the laws of the State of Delaware applicable to
contracts made and to be performed in the State of Delaware. The Company and the
Purchaser irrevocably consent to the jurisdiction of the United States federal
courts and the state courts located in the County of New Castle, Delaware, in
any suit or proceeding based on or arising under this Agreement and irrevocably
agree that all claims in respect of such suit or proceeding may be determined in
such courts. The Company and the Purchaser irrevocably waive the defense of an
inconvenient forum to the maintenance of such suit or proceeding in such forum.
The Company and the Purchaser further agree that service of process upon the
Company mailed by first class mail shall be deemed in every respect effective
service of process upon the Company in any such suit or proceeding. Nothing
herein shall affect the right of the Company or any Purchaser to serve process
in any other manner permitted by law. The Company and the Purchaser agree that a
final non-appealable judgment in any such suit or proceeding shall be conclusive
and may be enforced in other jurisdictions by suit on such judgment or in any
other lawful manner.

- 26 -

--------------------------------------------------------------------------------

 

     (b) Counterparts. This Agreement may be executed in two or more
counterparts, all of which shall be considered one and the same agreement and
shall become effective when counterparts have been signed by each party and
delivered to the other party. This Agreement, once executed by a party, may be
delivered to the other parties hereto by facsimile transmission of a copy of
this Agreement bearing the signature of the party so delivering this Agreement.
In the event any signature is delivered by facsimile transmission, the party
using such means of delivery shall cause the manually executed execution page(s)
hereof to be physically delivered to the other party within five days of the
execution hereof, provided that the failure to so deliver any manually executed
execution page shall not affect the validity or enforceability of this
Agreement.
     (c) Construction. Whenever the context requires, the gender of any word
used in this Agreement includes the masculine, feminine or neuter, and the
number of any word includes the singular or plural. Unless the context otherwise
requires, all references to articles and sections refer to articles and sections
of this Agreement, and all references to schedules are to schedules attached
hereto, each of which is made a part hereof for all purposes. The descriptive
headings of the several articles and sections of this Agreement are inserted for
purposes of reference only, and shall not affect the meaning or construction of
any of the provisions hereof.
     (d) Severability. If any provision of this Agreement shall be invalid or
unenforceable in any jurisdiction, such invalidity or unenforceability shall not
affect the validity or enforceability of the remainder of this Agreement or the
validity or enforceability of this Agreement in any other jurisdiction.
     (e) Entire Agreement; Amendments. This Agreement and the other Transaction
Documents (including any schedules and exhibits hereto and thereto) contain the
entire understanding of the Purchaser, the Company, their affiliates and persons
acting on their behalf with respect to the matters covered herein and therein
and, except as specifically set forth herein or therein, neither the Company nor
the Purchaser make any representation, warranty, covenant or undertaking with
respect to such matters. No provision of this Agreement may be waived other than
by an instrument in writing signed by the party to be charged with enforcement,
and no provision of this Agreement may be amended other than by an instrument in
writing signed by the Company and the Purchaser.
     (f) Notices. Any notices required or permitted to be given under the terms
of this Agreement shall be in writing and sent by certified or registered mail
(return receipt requested) or delivered personally, by nationally recognized
overnight carrier or by confirmed facsimile transmission, and shall be effective
five days after being placed in the mail, if mailed, or upon receipt or refusal
of receipt, if delivered personally or by nationally recognized overnight
carrier or confirmed facsimile transmission, in each case addressed to a party
as provided herein. The initial addresses for such communications shall be as
follows, and each party shall provide notice to the other parties of any change
in such party’s address:
(i) If to the Company:
Remote Dynamics, Inc.
1155 Kas Drive, Suite 100

- 27 -

--------------------------------------------------------------------------------

 

Richardson, TX 75081
Telephone: (972) 301-2733
Facsimile: (972) 301-2633
Attention: J. Raymond Bilbao, Esquire
with a copy simultaneously transmitted by like means (which transmittal shall
not constitute notice hereunder) to:
Locke Liddell & Sapp LLP
2200 Ross Avenue
Suite 2200
Dallas, TX 75201-6776
Telephone: (214) 740-8570
Facsimile: (214) 756-8570
Attention: Stephen L. Sapp, Esquire
(ii) If to any Purchaser, to the address set forth under the Purchaser’s name on
the Execution Page hereto executed by the Purchaser.
     (g) Successors and Assigns. This Agreement shall be binding upon and inure
to the benefit of the parties and their successors and assigns. Except as
provided herein, the Company shall not assign this Agreement or any rights or
obligations hereunder. Any Purchaser may assign or transfer the Securities
pursuant to the terms of this Agreement and of such Securities, or assign the
Purchaser’s rights hereunder to any other person or entity in accordance with
applicable law.
     (h) Third Party Beneficiaries. This Agreement is intended for the benefit
of the parties hereto and their respective permitted successors and assigns, and
is not for the benefit of, nor may any provision hereof be enforced by, any
other person; provided, however, that Section 4(q) may be enforced by any
Purchaser’s affiliates and its or their advisors to the extent the same is
entitled to reimbursement of Expenses pursuant thereto.
     (i) Survival. The representations and warranties of the Company and the
agreements and covenants set forth in Sections 3, 4, 5 and 8 hereof shall
survive the Closing for a period of two years notwithstanding any due diligence
investigation conducted by or on behalf of any Purchaser. Moreover, none of the
representations and warranties made by the Company herein shall act as a waiver
of any rights or remedies any Purchaser may have under applicable U.S. federal
or state securities laws.
     (j) Publicity. The Company and the Purchaser shall have the right to
approve before issuance any press releases, SEC or, to the extent applicable,
NASD filings, or any other public statements with respect to the transactions
contemplated hereby; provided, however, that the Company shall be entitled,
without the prior approval of the Purchaser, to make any press release or SEC
or, to the extent applicable, NASD filings with respect to such transactions as
is required by applicable law and regulations (although the Purchaser shall be
consulted by the Company in connection with any such press release and filing
prior to its release and shall be provided with a copy thereof and must provide
specific consent to the use of their name in connection therewith,

- 28 -

--------------------------------------------------------------------------------

 

which consent shall not be withheld if Company counsel advises the Company in
writing that NASD rules or applicable law explicitly require the use of the
Purchaser’s name).
     (k) Further Assurances. Each party shall do and perform, or cause to be
done and performed, all such further acts and things, and shall execute and
deliver all such other agreements, certificates, instruments and documents, as
the other party may reasonably request in order to carry out the intent and
accomplish the purposes of this Agreement and the consummation of the
transactions contemplated hereby.
     (l) Indemnification. In consideration of the Purchaser’s execution and
delivery of this Agreement and the other Transaction Documents and purchase of
the Securities hereunder, and in addition to all of the Company’s other
obligations under this Agreement and the other Transaction Documents, from and
after the Closing, the Company shall defend, protect, indemnify and hold
harmless the Purchaser and each other holder of the Securities and all of their
stockholders, partners, members, officers, directors, employees and direct or
indirect investors and any of the foregoing persons’ agents or other
representatives (including, without limitation, those retained in connection
with the transactions contemplated by this Agreement, collectively, the
“Indemnitees”) from and against any and all actions, causes of action, suits,
claims, losses, costs, penalties, fees, liabilities and damages, and expenses in
connection therewith (irrespective of whether any such Indemnitee is a party to
the action for which indemnification hereunder is sought), and including
reasonable attorneys’ fees and disbursements (the “Indemnified Liabilities”),
incurred by any Indemnitee as a result of, or arising out of, or relating to
(i) any misrepresentation or breach of any representation or warranty made by
the Company in this Agreement, any other Transaction Document or any other
certificate, instrument or document contemplated hereby or thereby, (ii) any
breach of any covenant, agreement or obligation of the Company contained in this
Agreement, any other Transaction Document or any other certificate, instrument
or document contemplated hereby or thereby or (iii) any cause of action, suit,
claim, order, proceeding or process brought or made against such Indemnitee by a
third party (including for these purposes a derivative action brought on behalf
of the Company) and arising out of or resulting from (A) the execution,
delivery, performance or enforcement of this Agreement, any other Transaction
Document or any other certificate, instrument or document contemplated hereby or
thereby, (B) any transaction financed or to be financed in whole or in part,
directly or indirectly, with the proceeds of the issuance and sale of the
Securities, or (C) the status of the Purchaser or holder of the Securities as an
investor in the Company. To the extent that the foregoing undertaking by the
Company may be unenforceable for any reason, the Company shall make the maximum
contribution to the payment and satisfaction of each of the Indemnified
Liabilities which is permissible under applicable law. Except as otherwise set
forth herein, the mechanics and procedures with respect to the rights and
obligations under this Section 8(l) shall be the same as those set forth in
Section 6(c) of the Registration Rights Agreement.
     (m) Payment Set Aside. To the extent that the Company makes a payment or
payments to any Purchaser hereunder or pursuant to any of the other Transaction
Documents or any Purchaser enforces or exercises its rights hereunder or
thereunder, and such payment or payments or the proceeds of such enforcement or
exercise or any part thereof are subsequently invalidated, declared to be
fraudulent or preferential, set aside, recovered from, disgorged by or are
required to be refunded, repaid or otherwise restored to the Company, a trustee,
receiver or

- 29 -

--------------------------------------------------------------------------------

 

any other person under any law (including, without limitation, any bankruptcy
law, state or federal law, common law or equitable cause of action), then to the
extent of any such restoration the obligation or part thereof originally
intended to be satisfied shall be revived and continued in full force and effect
as if such payment had not been made or such enforcement or setoff had not
occurred.
     (n) Joint Participation in Drafting. Each party to this Agreement has
participated in the negotiation and drafting of this Agreement and the other
Transaction Documents. As such, the language used herein and therein shall be
deemed to be the language chosen by the parties hereto to express their mutual
intent, and no rule of strict construction will be applied against any party to
this Agreement.
     (o) Remedies. No provision of this Agreement or any other Transaction
Document providing for any remedy to a Purchaser shall limit any other remedy
which would otherwise be available to the Purchaser at law, in equity or
otherwise. Nothing in this Agreement or any other Transaction Document shall
limit any rights any Purchaser may have under any applicable federal or state
securities laws with respect to the investment contemplated hereby. The Company
acknowledges that a breach by it of its obligations hereunder will cause
irreparable harm to the Purchaser by vitiating the intent and purpose of the
transactions contemplated hereby. Accordingly, the Company acknowledges that the
remedy at law for a breach of its obligations hereunder (including, but not
limited to, its obligations pursuant to Section 5 hereof) will be inadequate and
agrees, in the event of a breach or threatened breach by the Company of the
provisions of this Agreement (including, but not limited to, its obligations
pursuant to Section 5 hereof), that the Purchaser shall be entitled, in addition
to all other available remedies, to an injunction restraining any breach and
requiring immediate issuance and transfer of the Securities, without the
necessity of showing economic loss and without any bond or other security being
required.
     (p) Knowledge. As used in this Agreement, the term “knowledge” of any
person or entity shall mean and include (i) actual knowledge and (ii) that
knowledge which a reasonably prudent business person could have obtained in the
management of his or her business affairs after making due inquiry and
exercising due diligence which a prudent business person should have made or
exercised, as applicable, with respect thereto.
[REMAINDER OF PAGE LEFT BLANK INTENTIONALLY]

- 30 -

--------------------------------------------------------------------------------

 

     IN WITNESS WHEREOF, the undersigned Purchaser and the Company have caused
this Agreement to be duly executed as of the date first above written.
REMOTE DYNAMICS, INC.

         
By:
  /s/ W. Michael Smith               Name: W. Michael Smith     Title: Chief
Operating Officer    

PURCHASER:
SDS CAPITAL GROUP SPC, LTD. for itself and on behalf of its Class A Segregated
portfolio, Class B Segregated portfolio, Class C Segregated portfolio and all
future Segregated portfolios created by it from time to time
(Print or Type Name of Purchaser)

         
By:
  /s/ Kevin Johnson               Name: Kevin Johnson     Title: Managing
Director    

RESIDENCE: CAYMAN ISLANDS

     
ADDRESS:
  c/o SDS Management, LLC
 
  53 Forest Avenue, Second Floor
 
  Old Greenwich, CT 06870
 
  Telephone: (203) 967-5850
 
  Facsimile: (203) 967-5851
 
  Attention: Steven Derby

[SIGNATURE PAGE TO SECURITIES PURCHASE AGREEMENT]